Methotrexate combined with omalizumab for difficult to treat urticaria: a further step-up treatment?

P. Garbayo-Salmons; S. Butt; Robert S. Dawe

doi:10.1111/ced.14359

Methotrexate combined with omalizumab for difficult to treat urticaria: a further step-up treatment?

P. Garbayo-Salmons (Lead / Corresponding author)
, S. Butt
, Robert S. Dawe

Research output: Contribution to journal › Letter › peer-review

4 Citations (Scopus)

300 Downloads (Pure)

Abstract

Classically, chronic urticaria has been treated following a stepwise approach where Omalizumab and other immunosuppressants occupy the last step. Omalizumab and Methotrexate have both been used separately for the treatment of urticaria1,2 . We believe combination treatment with both agents is a valuable alternative for refractory chronic urticaria and other related diseases such as urticarial vasculitis. Here we report on two patients who responded to the combination treatment.

Original language	English
Pages (from-to)	350-351
Number of pages	2
Journal	Clinical and Experimental Dermatology
Volume	46
Issue number	2
Early online date	29 Jun 2020
DOIs	https://doi.org/10.1111/ced.14359
Publication status	Published - Mar 2021

ASJC Scopus subject areas

Dermatology

Access to Document

10.1111/ced.14359

Author Accepted ManuscriptAccepted author manuscript, 1.82 MB

Cite this

@article{89a4ca9ceb5f4988b651127e2720fa8f,

title = "Methotrexate combined with omalizumab for difficult to treat urticaria: a further step-up treatment?",

abstract = "Classically, chronic urticaria has been treated following a stepwise approach where Omalizumab and other immunosuppressants occupy the last step. Omalizumab and Methotrexate have both been used separately for the treatment of urticaria1,2 . We believe combination treatment with both agents is a valuable alternative for refractory chronic urticaria and other related diseases such as urticarial vasculitis. Here we report on two patients who responded to the combination treatment.",

author = "P. Garbayo-Salmons and S. Butt and Dawe, \{Robert S.\}",

note = "{\textcopyright} 2020 British Association of Dermatologists",

year = "2021",

month = mar,

doi = "10.1111/ced.14359",

language = "English",

volume = "46",

pages = "350--351",

journal = "Clinical and Experimental Dermatology",

issn = "0307-6938",

publisher = "Oxford University Press",

number = "2",

}

TY - JOUR

T1 - Methotrexate combined with omalizumab for difficult to treat urticaria

T2 - a further step-up treatment?

AU - Garbayo-Salmons, P.

AU - Butt, S.

AU - Dawe, Robert S.

PY - 2021/3

Y1 - 2021/3

N2 - Classically, chronic urticaria has been treated following a stepwise approach where Omalizumab and other immunosuppressants occupy the last step. Omalizumab and Methotrexate have both been used separately for the treatment of urticaria1,2 . We believe combination treatment with both agents is a valuable alternative for refractory chronic urticaria and other related diseases such as urticarial vasculitis. Here we report on two patients who responded to the combination treatment.

AB - Classically, chronic urticaria has been treated following a stepwise approach where Omalizumab and other immunosuppressants occupy the last step. Omalizumab and Methotrexate have both been used separately for the treatment of urticaria1,2 . We believe combination treatment with both agents is a valuable alternative for refractory chronic urticaria and other related diseases such as urticarial vasculitis. Here we report on two patients who responded to the combination treatment.

UR - https://www.scopus.com/pages/publications/85089370374

U2 - 10.1111/ced.14359

DO - 10.1111/ced.14359

M3 - Letter

C2 - 32598497

SN - 0307-6938

VL - 46

SP - 350

EP - 351

JO - Clinical and Experimental Dermatology

JF - Clinical and Experimental Dermatology

IS - 2

ER -

Methotrexate combined with omalizumab for difficult to treat urticaria: a further step-up treatment?

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this